Davis Polk advised J.P. Morgan Securities LLC and Piper Jaffray & Co. as joint book-running managers in connection with the initial public offering of 6,140,000 shares of common stock of Epocrates, Inc. The gross proceeds from the offering were approximately $98.6 million. Epocrates’ common stock is traded on the Nasdaq Global Market under the symbol “EPOC.”

Based in San Mateo, California, Epocrates, Inc. is a leading provider of mobile drug reference tools to health care professionals and interactive services to the health care industry.

The Davis Polk corporate team included partner Alan F. Denenberg and associates Shan Jiang and Daniel J. Luskin. Partner Rachel D. Kleinberg and associate M. Ryan LaRosa provided tax advice. Counsel Cynthia Akard provided employment advice. Counsel Marcie A. Goldstein of the New York office provided FINRA advice. Associate David R. Bauer of the New York office provided intellectual property advice. Jessica L. Talbot was the legal assistant for the transaction. Except as noted above, all members of the Davis Polk team are based in the Menlo Park office.